Genertec Universal Medical Group Company Limited

SEHK:2666 Rapporto sulle azioni

Cap. di mercato: HK$9.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Genertec Universal Medical Group Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Wang Wenbing

Amministratore delegato

CN¥4.5m

Compenso totale

Percentuale dello stipendio del CEO32.2%
Mandato del CEO7.7yrs
Proprietà del CEOn/a
Durata media del management1.5yrs
Durata media del Consiglio di amministrazione2.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

May 10
Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Feb 05
Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Jun 08
Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 08
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 31
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Aug 20
Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Apr 19
Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Mar 10
Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Feb 19
Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

Feb 01
Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

Jan 11
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Dec 21
What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Nov 30
Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Wang Wenbing rispetto agli utili di Genertec Universal Medical Group?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

CN¥2b

Mar 31 2024n/an/a

CN¥2b

Dec 31 2023CN¥4mCN¥1m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥2b

Dec 31 2022CN¥4mCN¥1m

CN¥2b

Sep 30 2022n/an/a

CN¥2b

Jun 30 2022n/an/a

CN¥2b

Mar 31 2022n/an/a

CN¥2b

Dec 31 2021CN¥2mCN¥731k

CN¥2b

Compensazione vs Mercato: La retribuzione totale di Wang ($USD 640.28K ) è circa la media per le aziende di dimensioni simili nel mercato Hong Kong ($USD 518.33K ).

Compensazione vs guadagni: La retribuzione di Wang è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Wang Wenbing (50 yo)

7.7yrs

Mandato

CN¥4,489,000

Compensazione

Mr. Wang Wenbing is General Manager of China Universal Leasing Co., Ltd since October 14, 2021. He has been Deputy General Manager of Genertec Universal Medical Group Company Limited (formerly known as Uni...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Wang Wenbing
CEO & Executive Director7.7yrsCN¥4.49mNessun dato
Lin Wang
Executive Director1.3yrsCN¥965.00kNessun dato
Shisu Chen
Executive Chairmanless than a yearNessun datoNessun dato
Shinan Wang
Chief Accounting Officer & General Counsel1.5yrsNessun datoNessun dato
Feng Qingming
Chief Medical Officerno dataNessun datoNessun dato
Wai Kam Ng
Company Secretary4.8yrsNessun datoNessun dato

1.5yrs

Durata media

50yo

Età media

Gestione esperta: Il team dirigenziale di 2666 non è considerato esperto (durata media 1.3 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Wang Wenbing
CEO & Executive Director3.1yrsCN¥4.49mNessun dato
Lin Wang
Executive Director1.3yrsCN¥965.00kNessun dato
Shisu Chen
Executive Chairmanless than a yearNessun datoNessun dato
Yinquan Li
Independent Non-Executive Director9.3yrsCN¥363.00kNessun dato
Zhiming Xu
Independent Non-executive Director2.3yrsCN¥363.00kNessun dato
Kai Kong Chan
Non-Executive Vice-Chairman2.3yrsNessun dato0.0016%
CN¥ 158.2k
Siu Lui Chow
Independent Non-Executive Director9.3yrsCN¥363.00kNessun dato
Ming Xu
Non-Executive Director2.3yrsNessun datoNessun dato
Chaoyin Tong
Non-Executive Director3.4yrsNessun datoNessun dato
Hiu Fung Chan
Independent Non-executive Director2.3yrsCN¥363.00kNessun dato
Ziyang Zhu
Non-Executive Director3.3yrsNessun datoNessun dato

2.3yrs

Durata media

55yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 2666 non è considerato esperto (durata media del mandato 2.2 anni), il che suggerisce un nuovo consiglio.